Cited 0 times in
Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.